Recent Advances in Stereoselective Drug Targeting

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Stereochemistry

Background:

• Stereoselective drugs are crucial for targeted therapies.
• Chirality significantly impacts drug efficacy and safety.
• Recent advancements have enabled the development of stereoselective drugs for various medical conditions.

Purpose of the Study:

• To review recent examples of medically important protein targets addressed by stereoselective drugs.
• To highlight the therapeutic potential of stereoselective agents in diverse disease areas.

Main Methods:

• Review of recent scientific literature on stereoselective drug development.
• Identification of key protein targets and corresponding stereoselective inhibitors or antagonists.
• Analysis of enantioselective and diastereoselective binding and inhibition mechanisms.

Main Results:

• Heat shock protein 90 (Hsp90) inhibitors show promise as anticancer agents.
• Transient receptor potential vanilloid type 1 (TRPV1) antagonists are emerging as new analgesics.
• Stereospecific inhibition of MTH1 offers a strategy for cancer treatment.
• Stereoselective binding to α1-acid glycoprotein transporter affects drug distribution.
• Metallohelical complexes and assemblies demonstrate potential in Alzheimer's disease, antimicrobial, and anticancer therapies by targeting amyloid and DNA.

Conclusions:

• Stereoselective drugs represent a significant advancement in precision medicine.
• Targeting specific protein conformations and nucleic acid structures with stereochemically defined molecules enhances therapeutic outcomes.
• Further research into stereoselective drug design will unlock new treatment possibilities for complex diseases.